Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 24% ± 8% | |
oligodendrocyte precursor cell | 11 studies | 25% ± 12% | |
smooth muscle cell | 8 studies | 18% ± 2% | |
GABAergic neuron | 8 studies | 36% ± 21% | |
glutamatergic neuron | 7 studies | 39% ± 25% | |
endothelial cell | 6 studies | 22% ± 5% | |
neuron | 5 studies | 28% ± 8% | |
pericyte | 5 studies | 19% ± 3% | |
interneuron | 5 studies | 39% ± 24% | |
fibroblast | 4 studies | 19% ± 3% | |
epithelial cell | 4 studies | 22% ± 4% | |
astrocyte | 4 studies | 24% ± 5% | |
GABAergic interneuron | 3 studies | 18% ± 3% | |
myofibroblast cell | 3 studies | 21% ± 3% | |
Mueller cell | 3 studies | 28% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 3050.90 | 2626 / 2642 | 100% | 31.00 | 705 / 705 |
breast | 100% | 2247.20 | 459 / 459 | 99% | 21.41 | 1110 / 1118 |
intestine | 100% | 4782.78 | 966 / 966 | 99% | 12.98 | 523 / 527 |
prostate | 100% | 3563.79 | 244 / 245 | 100% | 15.14 | 500 / 502 |
pancreas | 100% | 2667.05 | 328 / 328 | 99% | 14.25 | 176 / 178 |
esophagus | 99% | 5085.23 | 1427 / 1445 | 99% | 19.78 | 182 / 183 |
stomach | 99% | 2957.17 | 354 / 359 | 99% | 14.55 | 284 / 286 |
bladder | 100% | 6300.86 | 21 / 21 | 98% | 12.82 | 493 / 504 |
lung | 99% | 2585.92 | 574 / 578 | 98% | 16.62 | 1135 / 1155 |
thymus | 100% | 2157.66 | 652 / 653 | 97% | 11.34 | 589 / 605 |
uterus | 100% | 4287.19 | 170 / 170 | 97% | 15.72 | 446 / 459 |
ovary | 99% | 2088.22 | 178 / 180 | 98% | 13.20 | 421 / 430 |
skin | 100% | 1961.81 | 1802 / 1809 | 97% | 17.16 | 458 / 472 |
adrenal gland | 97% | 1765.77 | 250 / 258 | 95% | 15.43 | 219 / 230 |
kidney | 100% | 1783.11 | 89 / 89 | 92% | 10.73 | 826 / 901 |
liver | 81% | 753.81 | 182 / 226 | 59% | 5.72 | 240 / 406 |
blood vessel | 100% | 5757.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.44 | 29 / 29 |
spleen | 100% | 1812.10 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.56 | 45 / 45 |
adipose | 100% | 2024.97 | 1202 / 1204 | 0% | 0 | 0 / 0 |
heart | 82% | 944.95 | 704 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 63% | 5.36 | 50 / 80 |
peripheral blood | 22% | 332.65 | 204 / 929 | 0% | 0 | 0 / 0 |
muscle | 12% | 99.12 | 99 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032886 | Biological process | regulation of microtubule-based process |
GO_0051301 | Biological process | cell division |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0031463 | Cellular component | Cul3-RING ubiquitin ligase complex |
GO_0005819 | Cellular component | spindle |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | KLHL42 |
Protein name | Kelch-like protein 42 (Cullin-3-binding protein 9) (Ctb9) (Kelch domain-containing protein 5) Kelch like family member 42 |
Synonyms | KLHDC5 KIAA1340 |
Description | FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex required for mitotic progression and cytokinesis. The BCR(KLHL42) E3 ubiquitin ligase complex mediates the ubiquitination and subsequent degradation of KATNA1. Involved in microtubule dynamics throughout mitosis. . |
Accessions | Q9P2K6 F5H523 H0YGN2 ENST00000381271.7 ENST00000543254.1 ENST00000539176.1 |